References

1. A. Enomoto, H. Kimura, and A. Chairoungdua et al., “Molecular identification of a renal urate-anion exchanger that regulates blood urate levels,” Nature, vol. 417, no. 6887, pp. 447–452, 2002.

   View at: Publisher Site | Google Scholar

2. E. G. Butler, T. Ichida, H. Maruyama, R. Schulte-Hermann, and G. M. Williams, “Toxicological studies on a benzofurane derivative. II. Demonstration of peroxisome proliferation in rat liver,” Toxicology and Applied Pharmacology, vol. 106, no. 3, pp. 500–508, 1990.

   View at: Publisher Site | Google Scholar

3. P. D. Cornwell, A. T. De Souza, and R. G. Ulrich, “Profiling of hepatic gene expression in rats treated with fibric acid analogs,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 549, no. 1-2, pp. 131–145, 2004.

   View at: Publisher Site | Google Scholar

4. C. Kunishima, I. Inoue, T. Oikawa, and S. Katayama, “The metabolism, toxicity and pharmacological studies of benzbromarone (Urinorm),” The Journal of Saitama Medical School, vol. 30, no. 4, pp. 187–194, 2003 (Japanese).

   View at: Google Scholar

5. G. D. Girnun, F. E. Domann, S. A. Moore, and M. E. C. Robbins, “Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter,” Molecular Endocrinology, vol. 16, no. 12, pp. 2793–2801, 2002.

   View at: Publisher Site | Google Scholar

6. K. Schoonjans, J. Peinado-Onsurbe, and A.-M. Lefebvre et al., “${\text{PPAR}}_{\alpha }$ and ${\text{PPAR}}_{\gamma }$ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene,” The EMBO Journal, vol. 15, no. 19, pp. 5336–5348, 1996.

   View at: Google Scholar

7. G. Martin, K. Schoonjans, A.-M. Lefebvre, B. Staels, and J. Auwerx, “Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by ${\text{PPAR}}_{\alpha }$ and ${\text{PPAR}}_{\gamma }$ activators,” The Journal of Biological Chemistry, vol. 272, no. 45, pp. 28210–28217, 1997.

   View at: Publisher Site | Google Scholar

8. T. E. Johnson, R. Vogel, S. J. Rutledge, G. Rodan, and A. Schmidt, “Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells,” Endocrinology, vol. 140, no. 7, pp. 3245–3254, 1999.

   View at: Publisher Site | Google Scholar

9. T. Gebel, M. Arand, and F. Oesch, “Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver,” FEBS Letters, vol. 309, no. 1, pp. 37–40, 1992.

   View at: Publisher Site | Google Scholar

10. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor $\gamma$ (${\text{PPAR}}_{\gamma }$),” The Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995.

    View at: Publisher Site | Google Scholar

11. A. Okuno, H. Tamemoto, and K. Tobe et al., “Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats,” The Journal of Clinical Investigation, vol. 101, no. 6, pp. 1354–1361, 1998.

    View at: Google Scholar

12. N. Kiyosawa, K. Shiwaku, and M. Hirode et al., “Utilization of a one-dimensional score for surveying chemical-induced changes in expression levels of multiple biomarker gene sets using a large-scale toxicogenomics database,” The Journal of Toxicological Sciences, vol. 31, no. 5, pp. 433–448, 2006.

    View at: Publisher Site | Google Scholar

13. K. Tamura, A. Ono, T. Miyagishima, T. Nagao, and T. Urushidani, “Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators,” The Journal of Toxicological Sciences, vol. 31, no. 5, pp. 471–490, 2006.

    View at: Publisher Site | Google Scholar

14. E. H. Pierce and D. L. Chesler, “Possible association of granulomatous hepatitis with clofibrate therapy,” The New England Journal of Medicine, vol. 299, no. 6, p. 314, 1978.

    View at: Google Scholar

15. M. M. van der Klauw, P. M. Houtman, B. H. Ch. Stricker, and P. Spoelstra, “Hepatic injury caused by benzbromarone,” Journal of Hepatology, vol. 20, no. 3, pp. 376–379, 1994.

    View at: Publisher Site | Google Scholar

16. K. G. Tolman and J. Chandramouli, “Hepatotoxicity of the thiazolidinediones,” Clinics in Liver Disease, vol. 7, no. 2, pp. 369–379, 2003.

    View at: Publisher Site | Google Scholar

17. C.-Y. Ho, T.-H. Kuo, T.-S. Chen, S.-H. Tsay, F.-Y. Chang, and S.-D. Lee, “Fenofibrate-induced acute cholestatic hepatitis,” Journal of the Chinese Medical Association, vol. 67, no. 5, pp. 245–247, 2004.

    View at: Google Scholar

18. T. Oikawa, C. Kunishima, and Y. Adachi et al., “Metabolism study of benzbromarone: in vitro metabolism and pharmacokinetics in healthy volunteers,” The Journal of New Remedies and Clinics, vol. 53, no. 6, pp. 682–691, 2004 (Japanese).

    View at: Google Scholar